NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 32 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $69,000 | +155.6% | 20,200 | 0.0% | 0.00% | – |
| Q2 2015 | $27,000 | +237.5% | 20,200 | 0.0% | 0.00% | – |
| Q1 2015 | $8,000 | 0.0% | 20,200 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | -90.9% | 20,200 | 0.0% | 0.00% | – |
| Q3 2014 | $88,000 | -12.0% | 20,200 | 0.0% | 0.00% | – |
| Q2 2014 | $100,000 | -8.3% | 20,200 | 0.0% | 0.00% | – |
| Q1 2014 | $109,000 | -9.9% | 20,200 | 0.0% | 0.00% | – |
| Q4 2013 | $121,000 | -9.7% | 20,200 | 0.0% | 0.00% | – |
| Q3 2013 | $134,000 | +76.3% | 20,200 | +36.5% | 0.00% | – |
| Q2 2013 | $76,000 | – | 14,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|